Auto - Parts
Compare Stocks
5 / 10Stock Comparison
XPEL vs MPAA vs LCII vs DORM vs STRT
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
Auto - Recreational Vehicles
Auto - Parts
Auto - Parts
XPEL vs MPAA vs LCII vs DORM vs STRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Parts | Auto - Parts | Auto - Recreational Vehicles | Auto - Parts | Auto - Parts |
| Market Cap | $1.21B | $220M | $2.83B | $3.72B | $312M |
| Revenue (TTM) | $490M | $771M | $4.17B | $2.15B | $580M |
| Net Income (TTM) | $53M | $2M | $202M | $190M | $25M |
| Gross Margin | 42.5% | 19.2% | 24.1% | 40.7% | 16.8% |
| Operating Margin | 13.2% | 6.1% | 7.0% | 15.6% | 5.0% |
| Forward P/E | 20.7x | 15.3x | 13.4x | 15.0x | 11.9x |
| Total Debt | $23M | $201M | $1.24B | $633M | $11M |
| Cash & Equiv. | $51M | $9M | $223M | $49M | $85M |
XPEL vs MPAA vs LCII vs DORM vs STRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| XPEL, Inc. (XPEL) | 100 | 294.4 | +194.4% |
| Motorcar Parts of A… (MPAA) | 100 | 72.5 | -27.5% |
| LCI Industries (LCII) | 100 | 117.7 | +17.7% |
| Dorman Products, In… (DORM) | 100 | 178.1 | +78.1% |
| Strattec Security C… (STRT) | 100 | 578.0 | +478.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: XPEL vs MPAA vs LCII vs DORM vs STRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
XPEL carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 13.3%, EPS growth 12.1%, 3Y rev CAGR 13.7%
- PEG 0.90 vs LCII's 3.48
- 13.3% revenue growth vs STRT's 5.1%
- 10.8% margin vs MPAA's 0.3%
Among these 5 stocks, MPAA doesn't own a clear edge in any measured category.
LCII ranks third and is worth considering specifically for dividends.
- 3.9% yield; 9-year raise streak; the other 4 pay no meaningful dividend
DORM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.85
- 129.7% 10Y total return vs XPEL's 7.1%
- Lower volatility, beta 0.85, Low D/E 42.9%, current ratio 3.09x
- Beta 0.85, current ratio 3.09x
STRT is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (11.9x vs 15.0x)
- +120.7% vs DORM's +0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.3% revenue growth vs STRT's 5.1% | |
| Value | Lower P/E (11.9x vs 15.0x) | |
| Quality / Margins | 10.8% margin vs MPAA's 0.3% | |
| Stability / Safety | Beta 0.85 vs STRT's 1.53 | |
| Dividends | 3.9% yield; 9-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +120.7% vs DORM's +0.5% | |
| Efficiency (ROA) | 14.2% ROA vs MPAA's 0.2%, ROIC 19.5% vs 6.2% |
XPEL vs MPAA vs LCII vs DORM vs STRT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
XPEL vs MPAA vs LCII vs DORM vs STRT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
XPEL leads in 2 of 6 categories
STRT leads 1 • LCII leads 1 • MPAA leads 0 • DORM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
XPEL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LCII is the larger business by revenue, generating $4.2B annually — 8.5x XPEL's $490M. XPEL is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to MPAA's 0.3%. On growth, XPEL holds the edge at +13.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $490M | $771M | $4.2B | $2.2B | $580M |
| EBITDAEarnings before interest/tax | $77M | $49M | $385M | $377M | $33M |
| Net IncomeAfter-tax profit | $53M | $2M | $202M | $190M | $25M |
| Free Cash FlowCash after capex | $58M | $30M | $245M | $71M | $58M |
| Gross MarginGross profit ÷ Revenue | +42.5% | +19.2% | +24.1% | +40.7% | +16.8% |
| Operating MarginEBIT ÷ Revenue | +13.2% | +6.1% | +7.0% | +15.6% | +5.0% |
| Net MarginNet income ÷ Revenue | +10.8% | +0.3% | +4.8% | +8.8% | +4.3% |
| FCF MarginFCF ÷ Revenue | +11.8% | +3.9% | +5.9% | +3.3% | +10.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.1% | -9.9% | +4.3% | +4.2% | -4.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +19.4% | -18.2% | +30.4% | -23.5% | -41.7% |
Valuation Metrics
Evenly matched — MPAA and STRT each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 15.4x trailing earnings, LCII trades at a 35% valuation discount to XPEL's 23.8x P/E. Adjusting for growth (PEG ratio), XPEL offers better value at 1.04x vs LCII's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.2B | $220M | $2.8B | $3.7B | $312M |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $412M | $3.8B | $4.3B | $238M |
| Trailing P/EPrice ÷ TTM EPS | 23.76x | -11.59x | 15.38x | 18.75x | 16.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.70x | 15.29x | 13.38x | 15.05x | 11.91x |
| PEG RatioP/E ÷ EPS growth rate | 1.04x | — | 4.01x | 1.25x | — |
| EV / EBITDAEnterprise value multiple | 15.62x | 8.19x | 9.57x | 10.41x | 6.35x |
| Price / SalesMarket cap ÷ Revenue | 2.55x | 0.29x | 0.69x | 1.75x | 0.55x |
| Price / BookPrice ÷ Book value/share | 4.27x | 0.88x | 2.13x | 2.59x | 1.23x |
| Price / FCFMarket cap ÷ FCF | 19.28x | 5.39x | 10.16x | 49.18x | 4.83x |
Profitability & Efficiency
XPEL leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
XPEL delivers a 19.1% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $1 for MPAA. STRT carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to LCII's 0.91x. On the Piotroski fundamental quality scale (0–9), LCII scores 8/9 vs XPEL's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.1% | +0.8% | +14.7% | +13.1% | +9.7% |
| ROA (TTM)Return on assets | +14.2% | +0.2% | +6.3% | +7.6% | +6.4% |
| ROICReturn on invested capital | +19.5% | +6.2% | +9.1% | +13.9% | +8.7% |
| ROCEReturn on capital employed | +22.2% | +6.6% | +10.8% | +18.5% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 8 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.08x | 0.78x | 0.91x | 0.43x | 0.05x |
| Net DebtTotal debt minus cash | -$28M | $192M | $1.0B | $584M | -$73M |
| Cash & Equiv.Liquid assets | $51M | $9M | $223M | $49M | $85M |
| Total DebtShort + long-term debt | $23M | $201M | $1.2B | $633M | $11M |
| Interest CoverageEBIT ÷ Interest expense | 4060.77x | 0.94x | 5.49x | 8.24x | 263.01x |
Total Returns (Dividends Reinvested)
STRT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in STRT five years ago would be worth $16,680 today (with dividends reinvested), compared to $4,829 for MPAA. Over the past 12 months, STRT leads with a +120.7% total return vs DORM's +0.5%. The 3-year compound annual growth rate (CAGR) favors STRT at 58.7% vs XPEL's -14.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -12.5% | -7.2% | -5.4% | +0.3% | -1.9% |
| 1-Year ReturnPast 12 months | +23.5% | +24.3% | +45.6% | +0.5% | +120.7% |
| 3-Year ReturnCumulative with dividends | -37.5% | +143.5% | +11.2% | +41.6% | +299.4% |
| 5-Year ReturnCumulative with dividends | -30.2% | -51.7% | -6.1% | +19.2% | +66.8% |
| 10-Year ReturnCumulative with dividends | +712.6% | -62.7% | +111.5% | +129.7% | +49.3% |
| CAGR (3Y)Annualised 3-year return | -14.5% | +34.5% | +3.6% | +12.3% | +58.7% |
Risk & Volatility
Evenly matched — DORM and STRT each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than STRT's 1.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. STRT currently trades 80.6% from its 52-week high vs MPAA's 63.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.33x | 0.99x | 0.99x | 0.85x | 1.53x |
| 52-Week HighHighest price in past year | $55.91 | $18.12 | $159.66 | $166.89 | $92.50 |
| 52-Week LowLowest price in past year | $31.26 | $9.09 | $82.29 | $98.44 | $33.50 |
| % of 52W HighCurrent price vs 52-week peak | +78.6% | +63.3% | +72.9% | +74.6% | +80.6% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 58.0 | 45.6 | 71.2 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 267K | 87K | 352K | 273K | 85K |
Analyst Outlook
LCII leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: XPEL as "Buy", MPAA as "Buy", LCII as "Hold", DORM as "Buy", STRT as "Hold". Consensus price targets imply 74.4% upside for MPAA (target: $20) vs 12.4% for DORM (target: $140). LCII is the only dividend payer here at 3.94% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $58.00 | $20.00 | $150.60 | $140.00 | — |
| # AnalystsCovering analysts | 6 | 7 | 14 | 16 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | — | +3.9% | — | — |
| Dividend StreakConsecutive years of raises | — | — | 9 | 2 | 0 |
| Dividend / ShareAnnual DPS | — | — | $4.59 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +2.2% | +4.5% | +1.1% | 0.0% |
XPEL leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). STRT leads in 1 (Total Returns). 2 tied.
XPEL vs MPAA vs LCII vs DORM vs STRT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is XPEL or MPAA or LCII or DORM or STRT a better buy right now?
For growth investors, XPEL, Inc.
(XPEL) is the stronger pick with 13. 3% revenue growth year-over-year, versus 5. 1% for Strattec Security Corporation (STRT). LCI Industries (LCII) offers the better valuation at 15. 4x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate XPEL, Inc. (XPEL) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — XPEL or MPAA or LCII or DORM or STRT?
On trailing P/E, LCI Industries (LCII) is the cheapest at 15.
4x versus XPEL, Inc. at 23. 8x. On forward P/E, Strattec Security Corporation is actually cheaper at 11. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: XPEL, Inc. wins at 0. 90x versus LCI Industries's 3. 48x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — XPEL or MPAA or LCII or DORM or STRT?
Over the past 5 years, Strattec Security Corporation (STRT) delivered a total return of +66.
8%, compared to -51. 7% for Motorcar Parts of America, Inc. (MPAA). Over 10 years, the gap is even starker: XPEL returned +712. 6% versus MPAA's -62. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — XPEL or MPAA or LCII or DORM or STRT?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 85β versus Strattec Security Corporation's 1. 53β — meaning STRT is approximately 80% more volatile than DORM relative to the S&P 500. On balance sheet safety, Strattec Security Corporation (STRT) carries a lower debt/equity ratio of 5% versus 91% for LCI Industries — giving it more financial flexibility in a downturn.
05Which is growing faster — XPEL or MPAA or LCII or DORM or STRT?
By revenue growth (latest reported year), XPEL, Inc.
(XPEL) is pulling ahead at 13. 3% versus 5. 1% for Strattec Security Corporation (STRT). On earnings-per-share growth, the picture is similar: Motorcar Parts of America, Inc. grew EPS 60. 6% year-over-year, compared to 8. 1% for Dorman Products, Inc.. Over a 3-year CAGR, XPEL leads at 13. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — XPEL or MPAA or LCII or DORM or STRT?
XPEL, Inc.
(XPEL) is the more profitable company, earning 10. 8% net margin versus -2. 6% for Motorcar Parts of America, Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 4. 0% for STRT. At the gross margin level — before operating expenses — XPEL leads at 42. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is XPEL or MPAA or LCII or DORM or STRT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, XPEL, Inc. (XPEL) is the more undervalued stock at a PEG of 0. 90x versus LCI Industries's 3. 48x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Strattec Security Corporation (STRT) trades at 11. 9x forward P/E versus 20. 7x for XPEL, Inc. — 8. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MPAA: 74. 4% to $20. 00.
08Which pays a better dividend — XPEL or MPAA or LCII or DORM or STRT?
In this comparison, LCII (3.
9% yield) pays a dividend. XPEL, MPAA, DORM, STRT do not pay a meaningful dividend and should not be held primarily for income.
09Is XPEL or MPAA or LCII or DORM or STRT better for a retirement portfolio?
For long-horizon retirement investors, LCI Industries (LCII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
99), 3. 9% yield, +111. 5% 10Y return). Strattec Security Corporation (STRT) carries a higher beta of 1. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LCII: +111. 5%, STRT: +49. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between XPEL and MPAA and LCII and DORM and STRT?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: XPEL is a small-cap quality compounder stock; MPAA is a small-cap quality compounder stock; LCII is a small-cap deep-value stock; DORM is a small-cap quality compounder stock; STRT is a small-cap deep-value stock. LCII pays a dividend while XPEL, MPAA, DORM, STRT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.